What's New on the FDA Drugs Site
April 12, 2017
- Drug Trials Snapshots: ZEJULA
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drugs@FDA Data Files (updated)
- Drug Trials Snapshots: XADAGO
- FDA-PDS Symposim, May 2, 2017
- FDA approves Ingrezza (valbenazine), the first drug to treat tardive dyskinesia
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
- Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505A and 505B of the Federal Food, Drug, and Cosmetic Act, as amended by the FDA Safety and Innovation Act of 2012 (FDASIA) (updated)
.png)
No hay comentarios:
Publicar un comentario